Customization: | Available |
---|---|
Assay: | 99%+ |
Product Name: | Mitomycin C |
Suppliers with verified business licenses
Audited by an independent third-party inspection agency
Production Name | Mitomycin C |
EINECS No | 200-008-6 |
Appearance | Shiny blue-purple crystals powder |
Molecular Formula | C15H18N4O5 |
Molecular Weight | 334.33 |
Density | 1.56g/cm3 |
Melting Point | 360ºC |
Boiling Point | 581.8°C at 760 mmHg |
Flash Point | 305.6°C |
Vapor Pressure | 1.59E-13mmHg at 25°C |
Storage | Keep in a cool, dry, dark location |
(1) It is a cell division inhibitors, nucleic acid inhibitors and phage inducer; an anti-tumor drugs in clinical use.
(2) This drug has a broad anti-tumor spectrum, and effective for gastric cancer, breast cancer. It has a certain effect on lung cancer, liver cancer, malignant lymphoma, Hodgkin's disease, reticular cell sarcoma, uterine cancer, leukemia, intestinal cancer and pancreatic cancer, but with a short remission. Combination with urokinase can improve the efficacy. The goods exert its function quickly, but the number of operators is not high, and it has a high toxicity. The goods and bleomycin as well as its derivatives --doxorubicin are anti-cancer drugs of antibiotic which can disrupt DNA. It can depolymerize DNA in the cell, inhibit DNA replication in proliferating cell. The LD50 of intravenous injection of mice is 5ml/kg. It acts as an anticancer drugs, commonly used in the treatment of digestive system cancers.